Valneva SE Stock Börse Stuttgart
Stocks
AYJ
FR0004056851
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Tradegate
06:52:32 2026-10-09 EDT
|
5-day change | 1st Jan Change | ||
| 2.585 EUR | +3.52% |
|
-4.00% | -34.19% |
| 10-08 | Valneva Says UK Revokes Chikungunya Virus Vaccine's Marketing Authorization; Shares Down Pre-Bell | MT |
| 10-08 | Valneva: United Kingdom Withdraws IXCHIQ Authorization |  |
| Market Cap | 471M 528M 440M 399M 752M 51.11B 759M 5.28B 2.06B 25.97B 1.98B 1.94B 83.53B | P/E 2026 * |
-5.7x | P/E 2027 * | 9x |
|---|---|---|---|---|---|
| Enterprise Value | 605M 677M 564M 513M 965M 65.61B 974M 6.78B 2.65B 33.34B 2.54B 2.49B 107B | EV / Sales 2026 * |
4.01x | EV / Sales 2027 * | 1.88x |
| Free-Float |
89.26% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| VLA | Real-time | |
CBOE
| VLAt | Real-time | |
|
Tradegate
| AYJ | Real-time | |
|
Xetra
| AYJ | Delayed | |
|
Deutsche Boerse AG
| AYJ | Delayed | |
|
Boerse Muenchen
| AYJ | Real-time | |
|
Börse Stuttgart
| AYJ | Delayed | |
|
Wiener Boerse
| VLA | End-of-day quote | |
|
OTC Markets
| INRLF | Delayed | |
|
CBOE
| 0OB3 | Real-time | |
|
Borsa Italiana
| 4VLA | End-of-day quote |
Last Transcript: Valneva SE
| 1 week | -4.00% | ||
| Current month | -7.48% | ||
| 1 month | -14.28% | ||
| 3 months | +10.44% | ||
| 6 months | -6.76% | ||
| Current year | -34.19% |
| 1 week | 2.44 |  | 2.66 |
| 1 month | 2.44 | | 2.92 |
| 3 years | 1.74 | | 7.1 |
| 5 years | 1.74 | | 30.5 |
| 10 years | 1.74 | | 30.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | - | |
Peter Buhler
DFI | Director of Finance/CFO | 56 | 2021-07-28 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 2023-12-19 | |
James Sulat
BRD | Director/Board Member | 75 | 2013-03-06 |
| Chairman | 65 | 2023-12-19 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.52% | -4.00% | -46.55% | -53.98% | 528M | |
| -3.19% | -3.19% | +44.60% | +87.98% | 72.13B | |
| +4.85% | -9.22% | +6.56% | +58.50% | 49.41B | |
| +1.05% | +0.53% | +4.48% | +32.54% | 47.24B | |
| -6.35% | -8.63% | +293.39% | +651.28% | 40.32B | |
| +0.30% | -0.71% | +29.05% | +30.33% | 42.61B | |
| -3.82% | -2.41% | -0.27% | +101.36% | 39.81B | |
| -2.13% | -2.18% | +7.51% | +50.31% | 30.52B | |
| -3.35% | -4.95% | -13.38% | -17.22% | 23.13B | |
| +2.67% | +7.13% | +17.09% | -0.78% | 21.09B | |
| Average | -1.10% | -3.66% | +34.25% | +94.03% | 40.7B | |
| Weighted average by Cap. | -1.15% | -3.85% | +46.53% | +118.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 151M 169M 141M 128M 241M 16.38B 243M 1.69B 662M 8.32B 635M 621M 26.76B | 283M 317M 264M 240M 452M 30.73B 456M 3.17B 1.24B 15.62B 1.19B 1.17B 50.22B |
| Net income | -81.11M -90.83M -75.67M -68.74M -129M -8.8B -131M -909M -355M -4.47B -341M -334M -14.38B | 53.07M 59.43M 49.51M 44.97M 84.63M 5.76B 85.46M 594M 232M 2.92B 223M 218M 9.41B |
| Net Debt | 134M 150M 125M 113M 213M 14.5B 215M 1.5B 586M 7.37B 562M 550M 23.7B | 62.48M 69.96M 58.28M 52.94M 99.63M 6.78B 101M 700M 274M 3.44B 263M 257M 11.07B |
| Date | Price | Change |
|---|---|---|
| 26-10-09 | €2.587 | +3.60% |
| 26-10-08 | €2.497 | -2.84% |
| 26-10-07 | €2.570 | +0.39% |
| 26-10-06 | €2.560 | +0.04% |
| 26-10-05 | €2.559 | +0.87% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VLA Stock
- AYJ Stock
Select your edition
All financial news and data tailored to specific country editions
